![](/img/cover-not-exists.png)
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma
William I. Bensinger, Sundar Jagannath, Robert Vescio, Elber Camacho, Jeffrey Wolf, David Irwin, Gerardo Capo, Marti McKinley, Phyllis Potts, David H. Vesole, Amitabha Mazumder, John Crowley, Pam BeckVolume:
148
Year:
2010
Language:
english
Pages:
7
DOI:
10.1111/j.1365-2141.2009.07981.x
File:
PDF, 155 KB
english, 2010